Cali Sin Tos Aim 2 - Trial NCT06338462
Access comprehensive clinical trial information for NCT06338462 through Pure Global AI's free database. This phase not specified trial is sponsored by Yale University and is currently Not yet recruiting. The study focuses on Tuberculosis. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Yale University
Timeline & Enrollment
N/A
May 01, 2024
May 01, 2025
Primary Outcome
Implementation of the mHealth strategy to assess feasibility.,Oral specimen collection to assess feasibility.
Summary
The overall objective of this Aim is to design and iteratively adapt a home-based, mHealth-
 and oral testing facilitated strategy for implementing tuberculosis (TB) contact tracing in
 Cali, Colombia. Investigators will employ an iterative, community-engaged, participatory
 co-design process to optimize the feasibility, acceptability, usability, and appropriateness
 of the mobile health (mHealth) and oral testing strategy, in preparation for a future,
 appropriately powered implementation-effectiveness trial.
 
 This protocol includes the baseline contact tracing protocol and the procedures for
 determining adaptations to the mHealth strategy (i.e., nominal group technique).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06338462
Device Trial